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Abstract 
Proteoglycans (PGs) are proteins that carry one or more negatively charged 
glycosaminoglycan (GAG) chains. Proteoglycans have been identified in essentially all 
multicellular organisms, and are implicated in a wide range of biological and 
pathological processes. To further decipher the influence of GAG glycosylation on 
biological and pathological events in humans, detailed structural characterization of 
PGs/GAGs is needed. However, studying the PGs/GAGs is very challenging and has 
been hampered by the limited number of analytical tools available. In this thesis work, 
we have developed and applied glycoproteomics and glycomics methods to characterize 
PGs and their GAG structures and investigated their possible influence on the cellular 
characteristics of insulin-producing cells. The workflow included isolation, enrichment, 
and enzymatic depolymerization of PG/GAG structures followed by structural analysis 
using liquid chromatography tandem mass spectrometry. We identified several different 
chondroitin/dermatan sulfate (CS/DS) and heparan sulfate (HS) PGs, some of which are 
novel PGs. Several of the identified PGs, such as chromogranin-A (CgA) belong to the 
granin family of secretory granules which are typically co-stored, co-processed and co-
released with the insulin hormone. Considering that several of the PGs identified belong 
to the granin family, and that the granins are important for the biogenesis of dense-core 
secretory granules, we started to explore the cellular effects of blocking the GAG 
glycosylation in rat INS-1 832/13 cells by using the CRISPR/Cas9 technique. Our data 
showed that B4galt7-KO clones had a major, but not always complete, block of the GAG 
glycosylation of the CgA protein. Furthermore, the cellular localization of CgA as well 
as its proteolytic processing was different in KO cells compared to WT cells. Further 
studies of the effects of downregulation of the GAG biosynthesis in these clones are 
ongoing.  
In summary, our structural findings may assist in elucidating the influence of GAG 
modifications on the storage, processing, and secretion of peptide hormones of endocrine 
cells, with particular relevance to insulin-secreting beta cells. Given the paramount 
importance of insulin on glucose homeostasis, these novel aspects of GAG glycosylation 
presented herein may provide new insights into diabetes research and future treatment 
strategies. 
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